U.S. Markets close in 3 hrs 49 mins

Analysts Have Revised BMY’s Target Price Downward in March

Margaret Patrick
Analysts Have Revised BMY’s Target Price Downward in March

How Major Pharmaceutical Stocks Are Positioned This Month(Continued from Prior Part)Analysts’ recommendations and target priceAnalysts expect an upside potential of 13.72% for Bristol-Myers Squibb (BMY) based on the company’s closing price on